Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Azzouzi, Abdel-Rahmène, Vincendeau, Sébastien, Barret, Eric, Cicco, Antony, Kleinclauss, François, van der Poel, Henk G, Stief, Christian G, Rassweiler, Jens, Salomon, Georg, Solsona, Eduardo, AlcarazVolume:
18
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30661-1
Date:
February, 2017
File:
PDF, 305 KB
english, 2017